Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases

REFERENCES

• Pearson KJ, Baur JA, Lewis KN, Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. [Research Support, NIH, Extramural Research Support, NIH, Intramural Research Support, Non-U.S. Gov't]. 2008 Aug;8(2):157–168.
   PubMed Web of Science ®Google Scholar
• Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev. 2007 Oct;128(10):546–552.
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Resveratrol improves health and survival of mice on a high-calorie diet. Nature [Research Support, NIH, Extramural Research Support, Non-US Gov't]. 2006 Nov 16;444(7117):337–342.
   PubMed Web of Science ®Google Scholar
• Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z, Rosen RT. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J Agric Food Chem. [Research Support, Non-US Gov't]. 2000 Feb;48(2):253–256.
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Yan J, Ng E, A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Vitic.1995 June 1, 1995;46(2):159–165.
   Google Scholar
• McMurtrey KD, Minn J, Pobanz K, Schultz TP. Analysis of wines for resveratrol using direct injection high-pressure liquid chromatography with electrochemical detection. J Agric Food Chem. 1994;42(10):2077–2080.
   Google Scholar
• Pezet R, Pont V, Cuenat P. Method to determine resveratrol and pterostilbene in grape berries and wines using high-performance liquid chromatography and highly sensitive fluorimetric detection. J Chromatogr. A 1994;663(2):191–197.
   Web of Science ®Google Scholar
• Romero Perez P, Amat Cecilia M, Rafie Mazketli W, Merenciano Cortina FJ, Laforga Canales JB. [Epididymal adenomatoid tumor: review of the national literature and report of a case]. Actas Urologicas Espanolas. [Case Reports Review]. 1996 Oct;20(9):839–843.
   Google Scholar
• Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992 Jun 20;339(8808):1523–1526.
   PubMed Web of Science ®Google Scholar
• Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology. [Research Support, Non-US Gov't]. 1998 Mar;9(2):184–188.
   Google Scholar
• Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharmaceut Bull.1982 May;30(5):1766–1770.
   PubMed Web of Science ®Google Scholar
• Ragazzi E, Froldi G, Fassina G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol Res Commun. [Comparative Study In Vitro]. 1988 Dec;20 (Suppl 5):79–82.
   Google Scholar
• Bertelli AA, Giovannini L, Giannessi D, Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue Reactions. 1995;17(1):1–3.
   PubMedGoogle Scholar
• Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. [Letter]. 1993 Apr 24;341(8852):1103–1104.
   PubMed Web of Science ®Google Scholar
• Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation. 2007 Apr;30(1–2):1–6.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Shioi T, Izumi T. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J. [Research Support, Non-US Gov't]. 2007 Mar;71(3):397–404.
   Google Scholar
• Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P. Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol. [Comparative Study Research Support, NIH, Extramural Research Support, Non-US Gov't]. 2007 Dec;72(6):1508–1521.
   Google Scholar
• Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Topics Med Chem. [Review]. 2007;7(3):311–340.
   PubMed Web of Science ®Google Scholar
• Samuelsson B. On the incorporation of oxygen in the conversion of 8,11,14-eicosatrienoic acid to prostaglandin E1. J Am Chem Soc. 1965;87(13):3011–3013.
   Google Scholar
• Hamberg M, Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. [In Vitro]. 1973 Mar;70(3):899–903.
   Google Scholar
• Hamberg M, Samuelsson B. Prostaglandin endoperoxides: novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404.
   Google Scholar
• Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. [Review]. 2008 Oct;14(10):461–469.
   PubMed Web of Science ®Google Scholar
• Boyce JA. Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med. [Research Support, NIH, ExtramuralResearch Support, Non-US Gov't Review]. 2008 Aug;8(5):335–349.
   Google Scholar
• Mathis S, Jala VR, Haribabu B. Role of leukotriene B4 receptors in rheumatoid arthritis. Autoimmun Rev. [Research Support, NIH, Extramural Review]. 2007 Nov;7(1):12–17.
   Google Scholar
• Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. [Research Support, NIH, Extramural Research Support, Non-U.S. Gov't Review]. 2010 Mar;10(3):181–193.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Chung WJ, Michaluart P, Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem. [Research Support, U.S. Gov't, PHS]. 1998 Aug 21;273(34):21875–21882.
   PubMed Web of Science ®Google Scholar
• Xie W, Herschman HR. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem. [Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS]. 1995 Nov 17;270(46):27622–27628.
   Google Scholar
• Inoue H, Nanayama T, Hara S, Yokoyama C, Tanabe T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. [Research Support, Non-U.S. Gov't]. 1994 Aug 15;350(1):51–54.
   Google Scholar
• Jang M, Cai L, Udeani GO, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. [Research Support, U.S. Gov't, PHS]. 1997 Jan 10;275(5297):218–220.
   PubMed Web of Science ®Google Scholar
• Zykova TA, Zhu F, Zhai X, Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinogen. [Research Support, NIH, Extramural]. 2008 Oct;47(10):797–805.
   Google Scholar
• Szewczuk LM, Forti L, Stivala LA, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. [Research Support, Non-U.S. Gov't]. 2004 May 21;279(21):22727–22737.
   Google Scholar
• Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. [Research Support, U.S. Gov't, PHS Review]. 1998;16: 225–260.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS Review]. 2000;18:621–663.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 2002 Apr;109 (Suppl):S81–S96.
   Google Scholar
• Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov. [Review]. 2004 Jan;3(1):17–26.
   PubMed Web of Science ®Google Scholar
• Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. [Research Support, Non-U.S. Gov't]. 2000 Jun 15;164(12):6509–6519.
   PubMed Web of Science ®Google Scholar
• Estrov Z, Shishodia S, Faderl S, Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 2003 Aug 1;102(3):987–995.
   PubMed Web of Science ®Google Scholar
• Adhami VM, Afaq F, Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia. [Research Support, U.S. Gov't, PHS]. 2003 Jan-Feb;5(1):74–82.
   Google Scholar
• Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol. [Research Support, Non-U.S. Gov't]. 1999 Feb;126(3):673–680.
   PubMed Web of Science ®Google Scholar
• Cho DI, Koo NY, Chung WJ, Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci. [Research Support, Non-U.S. Gov't]. 2002 Sep 13;71(17):2071–2082.
   PubMed Web of Science ®Google Scholar
• Murakami A, Matsumoto K, Koshimizu K, Ohigashi H. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages. Cancer Lett. [Comparative Study Research Support, Non-U.S. Gov't]. 2003 May 30;195(1):17–25.
   Google Scholar
• Pendurthi UR, Meng F, Mackman N, Rao LV. Mechanism of resveratrol-mediated suppression of tissue factor gene expression. Thromb Haemostasis. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 2002 Jan;87(1):155–162.
   Google Scholar
• Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002 Sep 1;62(17):4945–4954.
   PubMed Web of Science ®Google Scholar
• Leonard SS, Xia C, Jiang BH, Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun. 2003 Oct 3;309(4):1017–1026.
   PubMed Web of Science ®Google Scholar
• Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene. [Review]. 2001 Apr 30;20(19):2438–2452.
   PubMed Web of Science ®Google Scholar
• Vogt PK. Fortuitous convergences: the beginnings of JUN. Nat Rev Cancer. [Research Support, U.S. Gov't, PHS Review]. 2002 Jun;2(6):465–469.
   PubMed Web of Science ®Google Scholar
• Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. [Research Support, Non-U.S. Gov't Review]. 2003 Nov;3(11):859–868.
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 2001 Mar 1;410(6824):37–40.
   PubMed Web of Science ®Google Scholar
• Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS Review]. 1995 Jul 14;270(28):16483–16486.
   PubMed Web of Science ®Google Scholar
• Cavigelli M, Dolfi F, Claret FX, Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS]. 1995 Dec 1;14(23):5957–5964.
   PubMed Web of Science ®Google Scholar
• Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 1995 Jan 20;267(5196):389–393.
   PubMed Web of Science ®Google Scholar
• Hill CS, Wynne J, Treisman R. Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J. [Research Support, Non-U.S. Gov't]. 1994 Nov 15;13(22):5421–5432.
   Google Scholar
• Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 2001 Apr 30;20(19):2476–2489.
   PubMed Web of Science ®Google Scholar
• Ray A, Cohn L. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J Clin Invest. [Research Support, U.S. Gov't, PHS Review]. 1999 Oct;104(8):985–993.
   Google Scholar
• Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol. [Review]. 2002 Aug;3(8):715–720.
   PubMed Web of Science ®Google Scholar
• Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Prac Res Clin Rheumatol. [Research Support, Non-U.S. Gov't Review]. 2001 Dec;15(5):677–691.
   PubMed Web of Science ®Google Scholar
• Shahrara S, Huang Q, Mandelin AM, 2nd, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther. [Research Support, NIH, Extramural]. 2008;10(4):R93.
   Google Scholar
• Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 2000 Oct;21(10):479–483.
   Google Scholar
• Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. [Review]. 2000 Sep;1(3):199–205.
   PubMed Web of Science ®Google Scholar
• Rincon M, Derijard B, Chow CW, Davis RJ, Flavell RA. Reprogramming the signalling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. Genes Function. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 1997 Feb;1(1):51–68.
   Google Scholar
• Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, Angel P. Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J. [Research Support, Non-U.S. Gov't]. 2002 Dec 2;21(23):6321–6329.
   Google Scholar
• Wang ZY, Sato H, Kusam S, Sehra S, Toney LM, Dent AL. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J Immunol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 2005 Feb 15;174(4):2098–2105.
   Google Scholar
• Meixner A, Karreth F, Kenner L, Wagner EF. JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J. [Research Support, Non-U.S. Gov't]. 2004 Mar 24;23(6):1325–1335.
   Google Scholar
• Roy S, Charboneau R, Cain K, DeTurris S, Melnyk D, Barke RA. Deficiency of the transcription factor c-fos increases lipopolysaccharide-induced macrophage interleukin 12 production. Surgery. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS]. 1999 Aug;126(2):239–247.
   Google Scholar
• Kundu JK, Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res. [Research Support, Non-U.S. Gov't Review]. 2004 Nov 2;555(1–2): 65–80.
   Google Scholar
• Surh YJ, Ferguson LR. Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential–highlights of a symposium. Mutat Res. [Editorial Research Support, Non-U.S. Gov't Review]. 2003 Feb-Mar;523–524:1–8.
   PubMed Web of Science ®Google Scholar
• Chun KS, Kim SH, Song YS, Surh YJ. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis. [Research Support, Non-U.S. Gov't]. 2004 May;25(5):713–722.
   Google Scholar
• Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L, Bickers DR, Athar M. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol. [Research Support, NIH, Extramural]. 2006 Jul;15(7):538–546.
   Google Scholar
• Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 1994 Oct 21;269(42):26396–26401.
   PubMed Web of Science ®Google Scholar
• Schecter A, Birnbaum L, Ryan JJ, Constable JD. Dioxins: an overview. Environ Res. 2006;101(3):419–428.
   PubMed Web of Science ®Google Scholar
• Sun YV, Boverhof DR, Burgoon LD, Fielden MR, Zacharewski TR. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. [Comparative Study Res Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 2004;32(15):4512–4523.
   Google Scholar
• Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol. [Research Support, Non-U.S. Gov't Review]. 2009 Sep;30(9):447–454.
   PubMed Web of Science ®Google Scholar
• Casper RF, Quesne M, Rogers IM, Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol. [Research Support, Non-U.S. Gov't]. 1999 Oct;56(4):784–790.
   PubMedGoogle Scholar
• Ciolino HP, Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol.1999 Oct;56(4):760–767.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Basso AS, Iglesias AH, Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. [Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2008 May 1;453(7191):65–71.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. [Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2006 May 11;441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Hestermann EV, Brown M. Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-PHS Research Support, U.S. Gov't, PHS]. 2003 Nov;23(21):7920–7925.
   PubMedGoogle Scholar
• Oesch-Bartlomowicz B, Huelster A, Wiss O, Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc Natl Acad Sci U S A. [Research Support, Non-U.S. Gov't]. 2005 Jun 28;102(26):9218–9223.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med. [Research Support, Non-U.S. Gov't]. 2009 Jan 16;206(1):43–49.
   PubMed Web of Science ®Google Scholar
• Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation. 2011 Mar 3.
   Google Scholar
• Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 1999;17:593–623.
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol. [Research Support, Non-U.S. Gov't Review]. 2003 Jan;3(1):23–35.
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF, Fenwick PS, Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax. [Clinical Trial Controlled Clinical Trial In Vitro Research Support, Non-U.S. Gov't]. 2003 Nov;58(11):942–946.
   Google Scholar
• Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 1999 Apr 15;57(8):941–949.
   Google Scholar
• Ma ZH, Ma QY, Wang LC, Sha HC, Wu SL, Zhang M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm Res. 2005 Dec;54(12):522–527.
   Google Scholar
• Leiro J, Alvarez E, Arranz JA, Laguna R, Uriarte E, Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukocyte Biol. [Research Support, Non-U.S. Gov't]. 2004 Jun;75(6):1156–1165.
   Google Scholar
• Zhong M, Cheng GF, Wang WJ, Guo Y, Zhu XY, Zhang JT. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine. 1999 May;6(2):79–84.
   Google Scholar
• Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep. PR2005 May-Jun;57(3):390–394.
   Google Scholar
• Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol. [In Vitro Research Support, Non-U.S. Gov't]. 2000 Apr 1;59(7):865–870.
   PubMed Web of Science ®Google Scholar
• Bi XL, Yang JY, Dong YX, Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol. [Research Support, Non-U.S. Gov't]. 2005 Jan;5(1):185–193.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C, Immunobiology of dendritic cells. Annu Rev Immunol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS Review]. 2000;18:767–811.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. [Review]. 2003;21:685–711.
   PubMed Web of Science ®Google Scholar
• Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology. [Research Support, Non-U.S. Gov't]. 2010 Apr;129(4):525–535.
   Google Scholar
• Manavalan JS, Rossi PC, Vlad G, High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transplant Immunol. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, PHS]. 2003 Jul-Sep;11(3–4):245–258.
   PubMed Web of Science ®Google Scholar
• Svajger U, Anderluh M, Jeras M, Obermajer N. C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signalling. [Research Support, Non-U.S. Gov't Review]. 2010 Oct;22(10):1397–1405.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. [Review]. 1996 Mar;17(3):138–146.
   PubMedGoogle Scholar
• Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci. [Research Support, Non-U.S. Gov't]. 2001 Nov 21;70(1):81–96.
   PubMed Web of Science ®Google Scholar
• Boscolo P, del Signore A, Sabbioni E, Effects of resveratrol on lymphocyte proliferation and cytokine release. Ann Clin Lab Sci. 2003 Spring;33(2):226–231.
   Web of Science ®Google Scholar
• Gao X, Xu YX, Janakiraman N, Chapman RA, Gautam SC. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol. [Research Support, Non-U.S. Gov't]. 2001 Nov 1;62(9): 1299–1308.
   PubMed Web of Science ®Google Scholar
• Wu SL, Yu L, Pan CE, Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol. Pharmacol Res. 2006 Jul;54(1):19–23.
   PubMed Web of Science ®Google Scholar
• Yang Y, Paik JH, Cho D, Cho JA, Kim CW. Resveratrol induces the suppression of tumor-derived CD4+CD25 +regulatory T cells. Int Immunopharmacol. 2008 Apr;8(4):542–547.
   Google Scholar
• Zunino SJ, Storms DH. Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro. J Nutrition. [Research Support, Non-U.S. Gov't]. 2009 Aug;139(8): 1603–1608.
   PubMed Web of Science ®Google Scholar
• Soto BL, Hank JA, Darjatmoko SR, Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. Int Immunopharmacol. 2011 Nov;11(11):1877–1886.
   PubMed Web of Science ®Google Scholar
• Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One2010;5(12):e15627.
   PubMedGoogle Scholar
• Hsu KF, Wu CL, Huang SC, Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy. 2009 May;5(4):451–460.
   PubMed Web of Science ®Google Scholar
• Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One 2011;6(6):e20849.
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007 Sep;8(9):741–752.
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009 Jul;16(7):966–975.
   PubMed Web of Science ®Google Scholar
• Miki H, Uehara N, Kimura A, Resveratrol induces apoptosis via ROS-triggered autophagy in human colon. Int J Oncol. 2012 Apr;40(4):1020–1028.
   PubMed Web of Science ®Google Scholar
• Kepp O, Tesniere A, Schlemmer F, Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis. 2009 Apr;14(4):364–375.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res. 2010 Jun 15;16(12):3100–3104.
   PubMed Web of Science ®Google Scholar
• Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic. 1992 March 1, 1992;43(1):49–52.
   Web of Science ®Google Scholar
• Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, Mizrak B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflammation Res. [et al.] 2005 Apr;54(4):158–162.
   Google Scholar
• Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 2005 May;19(7):840–841.
   Google Scholar
• Chen G, Shan W, Wu Y, Ren L, Dong J, Ji Z. Synthesis and anti-inflammatory activity of resveratrol analogs. Chem Pharmaceut Bull. [Research Support, Non-U.S. Gov't]. 2005 Dec;53(12): 1587–1590.
   Google Scholar
• Lee SM, Yang H, Tartar DM, Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia. [Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2011 May;54(5):1136–1146.
   PubMed Web of Science ®Google Scholar
• Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival: collaborative transplant study. Rev Immunogenet. [Review]. 1999;1(3):334–342.
   Google Scholar
• Wu SL, Pan CE, Yu L, Meng KW. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model. Transplantation Proc. 2005 Jun;37(5):2354–2359.
   PubMed Web of Science ®Google Scholar
• la Porte C, Voduc N, Zhang G, Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet. [Controlled Clinical Trial Research Support, Non-U.S. Gov't]. 2010 Jul 1;49(7):449–454.
   PubMed Web of Science ®Google Scholar
• Boocock DJ, Faust GE, Patel KR, Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prevention. [Clinical Trial, Phase I Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2007 Jun;16(6):1246–1252.
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. [Clinical Trial Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2010 Nov 15;70(22):9003–9011.
   PubMed Web of Science ®Google Scholar
• Almeida L, Vaz-da-Silva M, Falcao A, Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutrition Food Res. [Randomized Controlled Trial]. 2009 May;53 Suppl 1:S7–S15.
   PubMedGoogle Scholar
• Chow HH, Garland LL, Hsu CH, Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila). [Clinical Trial Research Support, NIH, Extramural]. 2010 Sep;3(9):1168–1175.
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol. Exp Therapeut. 2002 Jul;302(1):369–373.
   PubMed Web of Science ®Google Scholar
• Asensi M, Medina I, Ortega A, Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biol Med. [In Vitro Research Support, Non-U.S. Gov't]. 2002 Aug 1;33(3):387–398.
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. [Research Support, Non-U.S. Gov't]. 2003 Feb;36(1):79–87.
   PubMed Web of Science ®Google Scholar
• Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. [Review]. 2011 Jan;1215:161–169.
   PubMed Web of Science ®Google Scholar
• Patel KR, Brown VA, Jones DJ, Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. [Clinical Trial Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2010 Oct 1;70(19):7392–7399.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discovery. [Review]. 2006 Jun;5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Korzeniewski K, A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. [Research Support, NIH, Extramural Research Support, Non-U.S. Gov't]. 2011 May;96(5):1409–1414.
   PubMed Web of Science ®Google Scholar